127 related articles for article (PubMed ID: 1967537)
21. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
22. A role for guanine ribonucleotides in the regulation of myeloid cell maturation.
Wright DG
Blood; 1987 Jan; 69(1):334-7. PubMed ID: 2878694
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
24. Increased inosinate dehydrogenase activity in mycophenolic acid resistant neuroblastoma cells.
Hodges SD; Fung E; Lin CC; Snyder FF
Adv Exp Med Biol; 1986; 195 Pt B():271-4. PubMed ID: 2876592
[No Abstract] [Full Text] [Related]
25. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
26. All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.
Yang KD; Mizobuchi T; Kharbanda SM; Datta R; Huberman E; Kufe DW; Stone RM
Blood; 1994 Jan; 83(2):490-6. PubMed ID: 8286746
[TBL] [Abstract][Full Text] [Related]
27. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
[No Abstract] [Full Text] [Related]
28. IMP-dehydrogenase (IMPDH), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), and phosphodiesterases (PDEs) expression during mycophenolic acid (MPA)-induced differentiation in human neuroblastoma cell lines.
Quaratino CP; Messina E; Arduini A; Angelini G; Spoto G; Gizzi F; Ruffini I; Odorisio M; Giacomello A
Adv Exp Med Biol; 1998; 431():439-41. PubMed ID: 9598106
[No Abstract] [Full Text] [Related]
29. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.
Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW
Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645
[TBL] [Abstract][Full Text] [Related]
30. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP.
Ji Y; Gu J; Makhov AM; Griffith JD; Mitchell BS
J Biol Chem; 2006 Jan; 281(1):206-12. PubMed ID: 16243838
[TBL] [Abstract][Full Text] [Related]
32. Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias.
Nagai M; Natsumeda Y; Konno Y; Hoffman R; Irino S; Weber G
Cancer Res; 1991 Aug; 51(15):3886-90. PubMed ID: 1677309
[TBL] [Abstract][Full Text] [Related]
33. Novel mycophenolic adenine bis(phosphonate)s as potent anticancer agents and inducers of cells differentiation.
Pankiewicz KW; Lesiak-Watanabe K
Nucleosides Nucleotides; 1999; 18(4-5):927-32. PubMed ID: 10432711
[TBL] [Abstract][Full Text] [Related]
34. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
[TBL] [Abstract][Full Text] [Related]
35. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
36. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
37. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.
Vethe NT; Ali AM; Reine PA; Andersen AM; Bremer S; Line PD; Rootwelt H; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):108-18. PubMed ID: 24061448
[TBL] [Abstract][Full Text] [Related]
40. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Herwig S; Su Q; Zhang W; Ma Y; Tempst P
Blood; 1996 Jan; 87(1):350-64. PubMed ID: 8547662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
